{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:21:24Z","timestamp":1792092084328,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":306,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1124\/molpharm.123.000789","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T01:14:50Z","timestamp":1704849290000},"page":"233-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action"],"prefix":"10.1016","volume":"105","author":[{"given":"John M.","family":"Gilchrist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5261-7382","authenticated-orcid":false,"given":"Nien-Du","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan D.","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.123.000789_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1085\/jgp.201511492","article-title":"The hitchhiker\u2019s guide to the voltage-gated sodium channel galaxy","volume":"147","author":"Ahern","year":"2016","journal-title":"J Gen Physiol"},{"key":"10.1124\/molpharm.123.000789_bib2","doi-asserted-by":"crossref","first-page":"aac5464","DOI":"10.1126\/science.aac5464","article-title":"Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist","volume":"350","author":"Ahuja","year":"2015","journal-title":"Science"},{"key":"10.1124\/molpharm.123.000789_bib3","doi-asserted-by":"crossref","first-page":"e0152405","DOI":"10.1371\/journal.pone.0152405","article-title":"Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release","volume":"11","author":"Alexandrou","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.123.000789_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1124\/molpharm.123.000789_bib5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The role of voltage-gated sodium channels in pain signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1124\/molpharm.123.000789_bib6","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1523\/JNEUROSCI.22-23-10277.2002","article-title":"Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons","volume":"22","author":"Blair","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.123.000789_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature07473","article-title":"Deconstructing voltage sensor function and pharmacology in sodium channels","volume":"456","author":"Bosmans","year":"2008","journal-title":"Nature"},{"key":"10.1124\/molpharm.123.000789_bib8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuropharm.2009.01.018","article-title":"Functional and pharmacological properties of human and rat NaV1.8 channels","volume":"56","author":"Browne","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/molpharm.123.000789_bib9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1469-7793.2001.t01-1-00855.x","article-title":"Slowly conducting afferents activated by innocuous low temperature in human skin","volume":"535","author":"Campero","year":"2001","journal-title":"J Physiol"},{"key":"10.1124\/molpharm.123.000789_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)81133-2","article-title":"From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels","volume":"26","author":"Catterall","year":"2000","journal-title":"Neuron"},{"key":"10.1124\/molpharm.123.000789_bib11","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1152\/jn.00542.2019","article-title":"Impact of the NaV1.8 variant, A1073V, on post-sigmoidectomy pain and electrophysiological function in rat sympathetic neurons","volume":"122","author":"Coates","year":"2019","journal-title":"J Neurophysiol"},{"key":"10.1124\/molpharm.123.000789_bib12","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.pain.2014.06.017","article-title":"Human sensory neurons: membrane properties and sensitization by inflammatory mediators","volume":"155","author":"Davidson","year":"2014","journal-title":"Pain"},{"key":"10.1124\/molpharm.123.000789_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916666083","article-title":"A SCN10A SNP biases human pain sensitivity","volume":"12","author":"Duan","year":"2016","journal-title":"Mol Pain"},{"key":"10.1124\/molpharm.123.000789_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918763275","article-title":"A variant in the SCN10A enhancer may affect human mechanical pain sensitivity","volume":"14","author":"Duan","year":"2018","journal-title":"Mol Pain"},{"key":"10.1124\/molpharm.123.000789_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.toxicon.2008.06.023","article-title":"Evidence for multiple effects of ProTxII on activation gating in Na(V)1.5","volume":"52","author":"Edgerton","year":"2008","journal-title":"Toxicon"},{"key":"10.1124\/molpharm.123.000789_bib16","doi-asserted-by":"crossref","first-page":"19444","DOI":"10.1073\/pnas.1216080109","article-title":"Gain-of-function Nav1.8 mutations in painful neuropathy","volume":"109","author":"Faber","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.123.000789_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1124\/molpharm.123.000789_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/vr.100255","article-title":"Culturing adult canine sensory neurons to optimise neural repair","volume":"170","author":"Gerhauser","year":"2012","journal-title":"Vet Rec"},{"key":"10.1124\/molpharm.123.000789_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fmed.2018.00324","article-title":"Homozygosity for the SCN10A polymorphism rs6795970 is associated with hypoalgesic inflammatory bowel disease phenotype","volume":"5","author":"Gonzalez-Lopez","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1124\/molpharm.123.000789_bib20","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1152\/jn.00113.2015","article-title":"Human Na(v)1.8: enhanced persistent and ramp currents contribute to distinct firing properties of human DRG neurons","volume":"113","author":"Han","year":"2015","journal-title":"J Neurophysiol"},{"key":"10.1124\/molpharm.123.000789_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.0000000000002333","article-title":"Sodium channel Nav1.8: emerging links to human disease","volume":"86","author":"Han","year":"2016","journal-title":"Neurology"},{"key":"10.1124\/molpharm.123.000789_bib22","doi-asserted-by":"crossref","unstructured":"Han C, Themistocleous AC, Estacion M, Dib-Hajj FB, Blesneac I, Macala L, Fratter C, Bennett DL, Waxman SG, Dib-Hajj SD (2018) The novel activity of carbamazepine as an activation modulator extends from NaV1.7 mutations to the NaV1.8-S242T mutant channel from a patient with painful diabetic neuropathy. Mol Pharmacol 94: 1256\u20131269.","DOI":"10.1124\/mol.118.113076"},{"key":"10.1124\/molpharm.123.000789_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp-2013-306095","article-title":"The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability","volume":"85","author":"Han","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/molpharm.123.000789_bib24","doi-asserted-by":"crossref","unstructured":"Hijma H J, Siebenga PS, Kam ML de, Groeneveld GJ (2021) A phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults. Pain Med 22:1814\u20131826.","DOI":"10.1093\/pm\/pnab032"},{"key":"10.1124\/molpharm.123.000789_bib25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/cts.13215","article-title":"A phase I, randomized, double\u2010blind, placebo\u2010controlled, single\u2010 and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX\u2010128, a highly selective Nav1.8 inhibitor, in healthy adults","volume":"15","author":"Hijma","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1124\/molpharm.123.000789_bib26","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/535S2a","article-title":"The pain drain","volume":"535","author":"Holmes","year":"2016","journal-title":"Nature"},{"key":"10.1124\/molpharm.123.000789_bib27","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.1523\/JNEUROSCI.2710-13.2013","article-title":"Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons","volume":"33","author":"Huang","year":"2013","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.123.000789_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208211119","article-title":"Structural basis for high-voltage activation and subtype-specific inhibition of human Nav1.8","volume":"119","author":"Huang","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.123.000789_bib29","unstructured":"Huang Y, Poslusney M, Ernst G, Barrow J (2020) inventors, Pyridine carboxamide compounds for inhibiting Nav1.8. WO 2020\/014246 Al. 2020 Jan 16."},{"key":"10.1124\/molpharm.123.000789_bib30","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1073\/pnas.0611364104","article-title":"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat","volume":"104","author":"Jarvis","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.123.000789_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1124\/molpharm.122.000593","article-title":"Use-dependent relief of inhibition of Nav1.8 channels by A-887826","volume":"103","author":"Jo","year":"2023","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.123.000789_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa2209870","article-title":"Selective inhibition of NaV1.8 with VX-548 for acute pain","volume":"389","author":"Jones","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1124\/molpharm.123.000789_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.joen.2022.09.004","article-title":"Association between single-nucleotide polymorphisms in candidate genes and success of pulpal anesthesia after inferior alveolar nerve block","volume":"49","author":"Karata\u015f","year":"2023","journal-title":"J Endod"},{"key":"10.1124\/molpharm.123.000789_bib34","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1517\/13543784.2015.1099627","article-title":"Discontinued neuropathic pain therapy between 2009-2015","volume":"24","author":"Knezevic","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/molpharm.123.000789_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/jm070637u","article-title":"Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain","volume":"51","author":"Kort","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/molpharm.123.000789_bib36","doi-asserted-by":"crossref","first-page":"eaay1050","DOI":"10.1126\/scitranslmed.aay1050","article-title":"Nav1.7 target modulation and efficacy can be measured in nonhuman primate assays","volume":"13","author":"Kraus","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1124\/molpharm.123.000789_bib37","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1152\/jn.1984.51.6.1434","article-title":"Time-intensity profiles of cutaneous pain in normal and hyperalgesic skin: a comparison with C-fiber nociceptor activities in monkey and human","volume":"51","author":"LaMotte","year":"1984","journal-title":"J Neurophysiol"},{"key":"10.1124\/molpharm.123.000789_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4161\/chan.4847","article-title":"muO conotoxins inhibit NaV channels by interfering with their voltage sensors in domain-2","volume":"1","author":"Leipold","year":"2007","journal-title":"Channels (Austin)"},{"key":"10.1124\/molpharm.123.000789_bib39","doi-asserted-by":"crossref","unstructured":"Lucas JW, Connor EM, Bose J (2021) Back, lower limb, and upper limb pain among U.S. adults, 2019. NCHS Data Brief 415:1\u20138.","DOI":"10.15620\/cdc:107894"},{"key":"10.1124\/molpharm.123.000789_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3959(00)00361-4","article-title":"Pain as a reason to visit the doctor: a study in Finnish primary health care","volume":"89","author":"M\u00e4ntyselk\u00e4","year":"2001","journal-title":"Pain"},{"key":"10.1124\/molpharm.123.000789_bib41","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1124\/jpet.107.134148","article-title":"A selective Nav1.8 sodium channel blocker, A-803467 [5-(4-chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], attenuates spinal neuronal activity in neuropathic rats","volume":"324","author":"McGaraughty","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.123.000789_bib42","doi-asserted-by":"crossref","first-page":"e0196791","DOI":"10.1371\/journal.pone.0196791","article-title":"Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V","volume":"13","author":"Moyer","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.123.000789_bib43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jpain.2015.05.002","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012","volume":"16","author":"Nahin","year":"2015","journal-title":"J Pain"},{"key":"10.1124\/molpharm.123.000789_bib44","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1038\/s41598-020-71135-2","article-title":"Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins","volume":"10","author":"Pajouhesh","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.123.000789_bib45","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1111\/bph.13092","article-title":"A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability","volume":"172","author":"Payne","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.123.000789_bib46","doi-asserted-by":"crossref","first-page":"115371","DOI":"10.1016\/j.ejmech.2023.115371","article-title":"Discovery of selective NaV1.8 inhibitors based on 5-chloro-2-(4,4-difluoroazepan-1-yl)-6-methyl nicotinamide scaffold for the treatment of pain","volume":"254","author":"Qin","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1124\/molpharm.123.000789_bib47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/jn.2001.86.2.629","article-title":"Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons","volume":"86","author":"Renganathan","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1124\/molpharm.123.000789_bib48","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1016\/j.bmc.2010.09.057","article-title":"Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain","volume":"18","author":"Scanio","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/molpharm.123.000789_bib49","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1038\/s41598-020-61852-z","article-title":"Neurotrophic effects of GM1 ganglioside, NGF, and FGF2 on canine dorsal root ganglia neurons in vitro","volume":"10","author":"Schwarz","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.123.000789_bib50","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1097\/j.pain.0000000000001973","article-title":"Quantitative differences in neuronal subpopulations between mouse and human dorsal root ganglia demonstrated with RNAscope in situ hybridization","volume":"161","author":"Shiers","year":"2020","journal-title":"Pain"},{"key":"10.1124\/molpharm.123.000789_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1085\/jgp.201210909","article-title":"Voltage-sensor movements describe slow inactivation of voltage-gated sodium channels I: wild-type skeletal muscle Na(V)1.4","volume":"141","author":"Silva","year":"2013","journal-title":"J Gen Physiol"},{"key":"10.1124\/molpharm.123.000789_bib52","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/mol.107.041046","article-title":"Inhibition of sodium channel gating by trapping the domain II voltage sensor with protoxin II","volume":"73","author":"Sokolov","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.123.000789_bib53","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/0333102419897623","article-title":"Familial trigeminal neuralgia\u2014a systematic clinical study with a genomic screen of the neuronal electrogenisome","volume":"40","author":"Stefano","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1124\/molpharm.123.000789_bib54","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1038\/s41598-017-14246-7","article-title":"Canine dorsal root ganglia satellite glial cells represent an exceptional cell population with astrocytic and oligodendrocytic properties","volume":"7","author":"Tongtako","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.123.000789_bib55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1152\/jn.1984.51.2.325","article-title":"Peripheral neural correlates of magnitude of cutaneous pain and hyperalgesia: simultaneous recordings in humans of sensory judgments of pain and evoked responses in nociceptors with C-fibers","volume":"51","author":"Torebj\u00f6rk","year":"1984","journal-title":"J Neurophysiol"},{"key":"10.1124\/molpharm.123.000789_bib56","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","article-title":"A classification of chronic pain for ICD-11","volume":"156","author":"Treede","year":"2015","journal-title":"Pain"},{"key":"10.1124\/molpharm.123.000789_bib57","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/nprot.2016.111","article-title":"Surgical extraction of human dorsal root ganglia from organ donors and preparation of primary sensory neuron cultures","volume":"11","author":"Valtcheva","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1124\/molpharm.123.000789_bib58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jnnp.44.7.600","article-title":"C nociceptor activity in human nerve during painful and non painful skin stimulation","volume":"44","author":"Van Hees","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/molpharm.123.000789_bib59","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/CIRCEP.115.003155","article-title":"Direct measurement of cardiac Na+ channel conformations reveals molecular pathologies of inherited mutations","volume":"8","author":"Varga","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1124\/molpharm.123.000789_bib60","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1523\/JNEUROSCI.21-20-07909.2001","article-title":"Gating properties of Na(v)1.7 and Na(v)1.8 peripheral nerve sodium channels","volume":"21","author":"Vijayaragavan","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.123.000789_bib61","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1523\/JNEUROSCI.0468-18.2018","article-title":"Increased resurgent sodium currents in Nav1.8 contribute to nociceptive sensory neuron hyperexcitability associated with peripheral neuropathies","volume":"39","author":"Xiao","year":"2019","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.123.000789_bib62","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cell.2018.12.018","article-title":"Structural basis of Nav1.7 inhibition by a gating-modifier spider toxin","volume":"176","author":"Xu","year":"2019","journal-title":"Cell"},{"key":"10.1124\/molpharm.123.000789_bib63","doi-asserted-by":"crossref","first-page":"e23235","DOI":"10.7554\/eLife.23235","article-title":"Voltage-gated Na+ currents in human dorsal root ganglion neurons","volume":"6","author":"Zhang","year":"2017","journal-title":"eLife"},{"key":"10.1124\/molpharm.123.000789_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2010.05.009","article-title":"A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats","volume":"59","author":"Zhang","year":"2010","journal-title":"Neuropharmacology"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24001019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24001019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.123.000789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:20:44Z","timestamp":1740745244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24001019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0026895X24001019"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.123.000789","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.123.000789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The Author(s)","name":"copyright","label":"Copyright"}]}}